Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis
Egile Nagusiak: | Shrimanker, R, Keene, O, Hynes, G, Wenzel, S, Yancey, S, Pavord, I |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
American Thoracic Society
2019
|
Antzeko izenburuak
-
Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
nork: Shrimanker, R, et al.
Argitaratua: (2018) -
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
nork: Price, D, et al.
Argitaratua: (2019) -
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
nork: David B. Price, et al.
Argitaratua: (2019-08-01) -
Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
nork: Jiang-Hua Li, et al.
Argitaratua: (2021-08-01) -
Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
nork: Howell, I, et al.
Argitaratua: (2024)